Edwin Gershom

Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.

Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.

Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.

Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.

Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.